Speaker illustration

Doctor Vidal Essebag

McGill University Health Centre, Montreal (Canada)

Member of:

European Society of Cardiology
European Heart Rythm Association

Concomitant anti-platelet therapy in warfarin-treated patients undergoing cardiac rhythm device implantation: a secondary analysis of the BRUISE CONTROL trial

Event: EHRA 2019

Topic: Device Complications and Lead Extraction

Session: Moderated ePosters 15: Implantable device therapy : the good, the bad and the ugly

Thumbnail

Cardiac resynchronization therapy programming to improve electrical synchrony: adjusting the atrioventricular conduction delay

Event: EHRA 2019

Topic: Cardiac Resynchronisation Therapy (CRT)

Session: Cardiac Resynchronization Therapy

Thumbnail

Randomized controlled trials of continued versus interrupted oral anti-coagulant at the time of device surgery: Combined analysis of BRUISE CONTROL 1 and 2

Event: EHRA 2018

Topic: Device Complications and Lead Extraction

Session: Late-Breaking Trials

Thumbnail

This platform is supported by

logo Novo Nordisk